Bladder Cancer - Results from #60

Phase I neoadjuvant study of intravesical recombinant fowlpox-GM-CSF (rF-GM-CSF) or fowlpox-TRICOM (rF-TRICOM) in patients with bladder carcinoma. June 28, 2019

Expression of miR-100 and miR-138 as prognostic biomarkers in Non- Muscle Invasive Bladder Cancer. June 27, 2019

Phase II trial of continuous treatment with sunitinib in patients with high-risk (BCG-refractory) non-muscle invasive bladder cancer. June 27, 2019

Clinical implications of molecular subtyping in bladder cancer. June 27, 2019

Influence of preoperative hydronephrosis and ureteral orifice involvement in the survival of patients undergoing radical cystectomy: A retrospective comparative study. June 26, 2019

Immunogenomic Analysis of Exceptional Responder to ALT-803 (IL-15 Analogue) in BCG Unresponsive Nonmuscle Invasive Bladder Cancer: A Case Series and Review of the Literature. June 26, 2019

DNA damage repair gene mutations and their association with tumor immune regulatory gene expression in muscle invasive bladder cancer subtypes. June 26, 2019

Comparison of two patients presenting with the clear cell variant of urothelial cell carcinoma of the urinary bladder: laser-assisted partial cystectomy for local disease versus chemotherapy for locally advanced disease. June 25, 2019

Integrative Metabolomic and Transcriptomic Analysis for the Study of Bladder Cancer. June 25, 2019

Staging the Host: Personalizing Risk Assessment for Radical Cystectomy Patients. June 25, 2019

Sex-specific Differences in the Quality of Treatment of Muscle-invasive Bladder Cancer Do Not Explain the Overall Survival Discrepancy. June 24, 2019

Multimodal Prehabilitation to Enhance Functional Capacity Following Radical Cystectomy: A Randomized Controlled Trial. June 24, 2019

Prognostic value and association with epithelial-mesenchymal transition and molecular subtypes of the proteoglycan biglycan in advanced bladder cancer. June 24, 2019

Pathological Outcomes for Patients Who Failed To Remain Under Active Surveillance for Low-risk Non-muscle-invasive Bladder Cancer: Update and Results from the Bladder Cancer Italian Active Surveillance Project. June 21, 2019

Reasons why not all Danish patients with muscle invasive bladder cancer receive neoadjuvant chemotherapy before radical cystectomy. June 21, 2019

Analysis of ceRNA network identifies prognostic circRNA biomarkers in bladder cancer. June 21, 2019

Impact of Body Mass Index and Pretreatment Hemoglobin Level on Prognosis Following Radical Cystectomy for Bladder Cancer in Males and Females. June 20, 2019

American Urological Association Non-muscle Invasive Bladder Cancer Risk Model Validation: Should patient age be added to the risk model? June 20, 2019

Clinical parameters outperform molecular subtypes for predicting outcome in bladder cancer: Results from multiple cohorts including TCGA. June 20, 2019

Survival Benefit Persists with Delayed Initiation of Adjuvant Chemotherapy following Radical Cystectomy for Locally Advanced Bladder Cancer. June 19, 2019

Page 4 of 297

E-Newsletters

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.